Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING LLC
GLOBETECH MEDIA
GLOBETECH PUBLISHING LLC

New Kit Enables Rapid PCR on Whole Blood Samples

By BiotechDaily International staff writers
Posted on 02 Dec 2013
A new kit is now available that allows biotech and other life science researchers to easily perform PCR (polymerase chain reaction) analyses on whole blood samples.

The Bioline (London, United Kingdom) MyTaq Blood-PCR Kit was specifically engineered to overcome PCR inhibitors typically present in blood samples such as anticoagulants (EDTA, citrate, and heparin) and to give significantly increased sensitivity and success rates even with demanding applications such as GC-rich templates or longer amplicons.

The MyTaq Blood-PCR Kit enables very fast and highly specific direct PCR from a wide range of human and animal whole blood samples. Its novel buffer system eliminates the need for complicated extraction or purification steps or use of additives.

The advanced formulation of the MyTaq Blood-PCR Kit allows fast cycling conditions to be used, without compromising PCR specificity or yield. The addition of an inert red dye in the mix also helps improve throughput. The kit's speed and high specificity make it ideal for multiplex PCR and high-throughput genotyping assays.

Marco Calzavara, president of Bioline, said, "With MyTaq Blood-PCR Kit, researchers can now quickly and easily achieve the purity and yield necessary for high-performance PCR direct from mammalian blood samples. This makes MyTaq Blood-PCR Kit the perfect complement to our widely used PCR reagents.”

Bioline is a wholly owned subsidiary of Meridian Life Science, Inc. (Cincinnati, OH, USA).

Richard L. Eberly, president of Meridian Life Science, Inc., said, "We are delighted to release the MyTaq Blood-PCR Kit which simplifies the process of PCR extractions from whole blood samples. We are committed to our life science customers and to bringing innovation and quality products; such as the MyTaq Blood-PCR Kits to the research laboratory, clinical diagnostic laboratories, and biotechnology companies."

Related Links:

Bioline
Meridian Life Science, Inc.



Channels

Drug Discovery

view channel
Image: Wafers like the one shown here are used to create “organ-on-a-chip” devices to model human tissue (Photo courtesy of Dr. Anurag Mathur, University of California, Berkeley).

Human Heart-on-a-Chip Cultures May Replace Animal Models for Drug Development and Safety Screening

Human heart cells growing in an easily monitored silicon chip culture system may one day replace animal-based model systems for drug development and safety screening. Drug discovery and development... Read more

Biochemistry

view channel
Image:  Model depiction of a novel cellular mechanism by which regulation of cryptochromes Cry1 and Cry2 enables coordination of a protective transcriptional response to DNA damage caused by genotoxic stress (Photo courtesy of the journal eLife, March 2015, Papp SJ, Huber AL, et al.).

Two Proteins Critical for Circadian Cycles Protect Cells from Mutations

Scientists have discovered that two proteins critical for maintaining healthy day-night cycles also have an unexpected role in DNA repair and protecting cells against genetic mutations that could lead... Read more

Business

view channel

“Softer” Mass Spec Techniques Gain Advantage in Biomarker Discovery

Two mass spectrometry (MS) technologies, MALDI and DESI, are increasing in applications as their effectiveness is established, according to Kalorama Information (New York, NY, USA) in its report “Proteomics Markets for Research and IVD Applications (Mass Spectrometry, Chromatography, Microarrays, Electrophoresis, Immunoassays,... Read more
 
Copyright © 2000-2015 Globetech Media. All rights reserved.